Support our Foundation of Myology project
1722 news items
A new gene linked to excitation-contraction coupling responsible for early-onset myopathy
On 26/11/2025
Spanish researchers report clinical and biological data from two unrelated consanguineous families in which a new gene for early-onset myopathy has been identified: the first…
M&M’s – Muscle Monday Seminar – 24 nov. – Dr Juliette Nectoux (France)
On 24/11/2025
Circulating free DNA and diagnosis – Focus on non-invasive prenatal diagnosis of monogenic disease Monday 24 November – from noon to 1pm (Paris time) Dr…
An original mode of administration in the treatment of refractory myasthenia gravis
On 24/11/2025
An international consortium of clinicians reports the results of a phase III open-label trial designed to assess the benefit and tolerability of a monoclonal antibody,…
More is now known about the pathophysiology of myotubularin
On 21/11/2025
The role of myotubularin, a muscle protein involved in X-linked recessive tubular myopathy, remains poorly understood. Researchers in Strasbourg and Toulouse report on their work…
ERN EURO-NMD webinar, 26 Nov.: Dr. Adela Della Marina (Germany)
On 21/11/2025
Myasthenia Gravis in the pediatric age Thursday 27 November 2025 – 16:00 – 17:00 Paris time Dr. Adela Della Marina (University Hospital Essen, Germany) >…
ERN EURO-NMD webinar, 26 Nov.: Prof. Dr. med. Andreas Meisel (Germany)
On 20/11/2025
Innovative therapies in Myasthenia Gravis Wednesday 26 November 2025 – 16:00 – 17:00 Paris time Prof. Dr. med. Andreas Meisel (Charité – Universitätsmedizin Berlin (CCM),…
The lysosome, a potential therapeutic target in DMD
On 20/11/2025
Researchers from the Institute of Myology and Généthon report pioneering work in the treatment of Duchenne muscular dystrophy (DMD): they started from the observation that…
Preclinical data for a drug candidate in Steinert disease
On 19/11/2025
A preclinical study evaluated SAR446268, an artificial microRNA produced by an AAV vector and targeting DMPK (dystrophin myotonic protein kinase) RNA designed by Sanofi, in…
Valentin Henriet awarded the ‘Best Technical Poster’ prize at the MYO-MRI+ 2025 conference
On 17/11/2025
Valentin Henriet is a PhD student in the Nuclear Magnetic Resonance (NMR) Imaging and Spectroscopy Laboratory. The poster entitled ‘Creatine-CEST-based pH mapping in healthy volunteer…
M&M’s – Muscle Monday Seminar – 17 nov. – Dr Mario Amendola (France)
On 17/11/2025
Gene Editing for DMD Treatment Monday 17 November – from noon to 1pm (Paris time) Dr Mario AMENDOLA (Genethon, Paris, France) On prior registration…
The Institute is developing an app using AI to assess motor function
On 14/11/2025
Romain Feigean is a researcher at the Neuromuscular Physiology and Evaluation Laboratory headed by Jean-Yves Hogrel at the Institute’s NIC. He is particularly involved in…
Ways to avoid liver toxicity from AAV
On 14/11/2025
Researchers at the Regenxbio pharmaceutical laboratory and American academics review the hepatic toxicity of adeno-associated viruses (AAV) in the context of human gene therapy, and…
ERN EURO-NMD webinar, 20 Nov.: Prof. Valentina Damato (Italy)
On 14/11/2025
Update on antibodies in Neuromuscular Junction Disorders Thursday 20 November 2025 – 16:00 – 17:00 Paris time Prof. Valentina Damato (University of Florence, Italy) >…
Towards better reuse of patient data in DMD
On 13/11/2025
A consortium bringing together patient associations, clinicians and methodologists from several countries reports on the FAIR project, which aims to better coordinate and standardise registries…
A standardised digital platform for Charcot-Marie-Tooth disease
On 12/11/2025
American and Australian researchers have developed a digital platform designed to facilitate the assessment, even remotely, of patients with Charcot-Marie-Tooth disease (CMT): the platform is…
A genetic predisposition to muscle toxicity from checkpoint inhibitors?
On 10/11/2025
Checkpoint inhibitors used in cancer treatment are likely to cause inflammatory myopathies and/or myocarditis. German and Swiss clinicians sought to identify risk factors for the…
A genetic isolate of limb-girdle muscular dystrophy in Uruguay
On 10/11/2025
Clinicians and researchers in Montevideo, Uruguay, report clinical and biological data from the world’s largest cohort of autosomal dominant limb-girdle muscular dystrophy linked to the…
Gene therapy appears to be more favourable than nusinersen in symptomatic type I SMA, according to an initial comparative analysis by the French SMA Registry.
On 07/11/2025
Based on data from 309 patients listed in the SMA France Registry and suffering from type I proximal spinal muscular atrophy (SMA), French clinicians conducted…
A new familial case of distal myopathy linked to the STPAN1 gene
On 07/11/2025
Belgian clinicians report clinical and biological data from a family diagnosed with distal myopathy linked to the STPAN1 gene: the clinical picture consisted of muscle…
ERN EURO-NMD webinar, 6 Nov.: Dr. Lorenzo Maggi (Italy) & Lutgarde Allard (EuMGA & Patient expert)
On 06/11/2025
How to evaluate patients with Myasthenia Gravis Thursday 6 November 2025 – 16:00 – 17:00 Paris time Dr. Lorenzo Maggi (Fondazione IRCCS Istituto Neurologico Carlo…
